IL6 and vulva cancer: Indeed, in vitro stimulation of tumor-containing TDLN single-cell suspensions from patients with either cervical or vulvar cancer with different TLR agonists failed to overcome apparent T-cell anergy but instead increased the release of immune-suppressive cytokines, such as IL-6 and IL-10 [113,140].